Cargando…

Patients not patents: Drug research and development as a public enterprise

Detalles Bibliográficos
Autor principal:	Gøtzsche, Peter C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2018
Materias:	Perspective
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5817403/ https://www.ncbi.nlm.nih.gov/pubmed/29243246 http://dx.doi.org/10.1111/eci.12875

Ejemplares similares

International patenting in ophthalmology: An analysis of its structure and relevance for the development of drugs and diagnostics
por: Mucke, Hermann AM, et al.
Publicado: (2009)

Multinational enterprises and natural disasters: Challenges and opportunities for IB research
por: Oh, Chang Hoon, et al.
Publicado: (2022)

Environmental Health: A Global Enterprise
por: Tilson, Hugh A., et al.
Publicado: (2009)

Rapid, responsive, relevant (R3) research: a call for a rapid learning health research enterprise
por: Riley, William T, et al.
Publicado: (2013)

The Legislative Approach and System Improvement of China’s Compulsory Licensing for Drug Patents
por: Cao, Zhang, et al.
Publicado: (2021)

A totally new system is needed for drug research and development
por: Gøtzsche, Peter C.
Publicado: (2018)

WIPO Re:Search: Catalyzing Public-Private Partnerships to Accelerate Tropical Disease Drug Discovery and Development
por: Manner, Cathyryne K., et al.
Publicado: (2019)

Rethink the patentability of human embryonic stem cell research findings: Relaxation based on benefit weighing
por: Chen, Jiajv, et al.
Publicado: (2021)

An algorithm strategy for precise patient monitoring in a connected healthcare enterprise
por: Hu, Xiao
Publicado: (2019)

Drug discovery and development: Role of basic biological research
por: Mohs, Richard C., et al.
Publicado: (2017)

Trends in worldwide nanotechnology patent applications: 1991 to 2008
por: Dang, Yan, et al.
Publicado: (2009)

Research on the Impact Mechanism of Organizational-Based Psychological Ownership on the Intelligent Transformation of Manufacturing Enterprises: Based on the Perspective of Technological Change
por: Wang, Yujie, et al.
Publicado: (2020)

Long-Term Use of Benzodiazepines, Stimulants and Lithium is Not Evidence-Based
por: Gøtzsche, Peter C.
Publicado: (2020)

Patent pooling to increase access to essential medicines
por: Burrone, Esteban, et al.
Publicado: (2019)

Research as an event: a novel approach to promote patient-focused drug development
por: Tsai, Jui-Hua, et al.
Publicado: (2018)

What is the impact of a research publication?
por: Fazel, Seena, et al.
Publicado: (2017)

Insights into the IgG heavy chain engineering patent landscape as applied to IgG4 antibody development
por: Dumet, Christophe, et al.
Publicado: (2019)

From bench to bar: careers in patent law for molecular biologists
por: Machin, Nathan A.
Publicado: (2013)

Enhancing antibody patent protection using epitope mapping information
por: Deng, Xiaoxiang, et al.
Publicado: (2017)

COVID-19 pandemic digitization lessons for sustainable development of micro-and small- enterprises
por: Bai, Chunguang, et al.
Publicado: (2021)

Building urban resilience through sustainability-oriented small- and medium-sized enterprises
por: Burch, Sarah, et al.
Publicado: (2022)

The Prevalence of Inappropriate Image Duplication in Biomedical Research Publications
por: Bik, Elisabeth M., et al.
Publicado: (2016)

Publication reform to safeguard wildlife from researcher harm
por: Field, Kate A., et al.
Publicado: (2019)

Patenting of University and Non-University Public Research Organisations in Germany: Evidence from Patent Applications for Medical Research Results
por: Tinnemann, Peter, et al.
Publicado: (2010)

Publication planning: promoting an ethics of transparency and integrity in biomedical research
por: DeTora, L., et al.
Publicado: (2015)

A new transdisciplinary research model to investigate and improve the health of the public
por: Pineo, Helen, et al.
Publicado: (2021)

Commercial Low Molecular Weight Heparins — Patent Ecosystem and Technology Paradigm for Quality Characterization
por: Iqbal, Zarina, et al.
Publicado: (2022)

Experiments in interdisciplinarity: Responsible research and innovation and the public good
por: Delgado, Ana, et al.
Publicado: (2018)

Averting a public health crisis in England’s coastal communities: a call for public health research and policy
por: Asthana, Sheena, et al.
Publicado: (2021)

Virtual Care and the Inverse Care Law: Implications for Policy, Practice, Research, Public and Patients
por: Alami, Hassane, et al.
Publicado: (2022)

Public enterprise : selected readings /
Publicado: (1968)

Evaluation of public involvement in research: time for a major re-think?
por: Edelman, Natalie, et al.
Publicado: (2015)

Applying Research to Public Health Questions: Biologically Relevant Exposures
por: Birnbaum, Linda S.
Publicado: (2010)

How to promote the accessibility of technology in the era of hESC patents—A comparative analysis of the systems of the US and China
por: Zhang, Wei, et al.
Publicado: (2023)

Setting the Terms for Zoonotic Diseases: Effective Communication for Research, Conservation, and Public Policy
por: Shapiro, Julie Teresa, et al.
Publicado: (2021)

Antimicrobial Drug Resistance, Regulation, and Research
por: Metlay, Joshua P., et al.
Publicado: (2006)

The Disconnect between China's Public Health and Public Security Responses to Injection Drug Use, and the Consequences for Human Rights
por: Koester, Stephen
Publicado: (2008)

Applying Research to Public Health Questions: Timing and the Environmentally Relevant Dose
por: Birnbaum, Linda S.
Publicado: (2009)

The Future of Research and Publication on Altered H5N1 Viruses
por: Herfst, Sander, et al.
Publicado: (2012)

Public Engagement with Biotechnologies Offers Lessons for the Governance of Geoengineering Research and Beyond
por: Stilgoe, Jack, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_9ejtlkm8vrrk185tkf388v24eh